04 Feb 2022
Go Back

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

Share this:

Other recent posts

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO
chevron-down